Last update 01 Nov 2024

Pfizer Biologics (Hangzhou) Co., Ltd

Subsidiary Company|
China

Overview

Related

1
Drugs associated with Pfizer Biologics (Hangzhou) Co., Ltd
Bevacizumab-BVZR
Target
VEGF-A
Mechanism
VEGF-A inhibitors [+1]
Active Org.
Pfizer Japan, Inc.Pfizer Japan, Inc. [+4]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Glioma [+27]
Inactive Indication
Advanced Lung Non-Small Cell Squamous Carcinoma [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date14 Feb 2019
2
Clinical Trials associated with Pfizer Biologics (Hangzhou) Co., Ltd
CTR20192551 / TerminatedPhase 1
一项在中国健康男性受试者中进行的 PF-06439535（中国）以及欧盟来源的贝伐珠单抗给药的2 组药代动力学研究
[Translation] A 2-arm pharmacokinetic study of PF-06439535 (China) and EU-derived bevacizumab in healthy Chinese male subjects
CTR20192191 / TerminatedPhase 3
PF-06439535（CN）联合紫杉醇-卡铂治疗中国晚期非鳞状非小细胞肺癌参与者的随机、双盲、桥接安全性和疗效研究
[Translation] A randomized, double-blind, bridging safety and efficacy study of PF-06439535 (CN) combined with paclitaxel-carboplatin in Chinese participants with advanced non-squamous non-small cell lung cancer
100 Clinical Results associated with Pfizer Biologics (Hangzhou) Co., Ltd
Login to view more data
0 Patents (Medical) associated with Pfizer Biologics (Hangzhou) Co., Ltd
Login to view more data
100 Deals associated with Pfizer Biologics (Hangzhou) Co., Ltd
Login to view more data
100 Translational Medicine associated with Pfizer Biologics (Hangzhou) Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Bevacizumab-BVZR
 ( VEGF-A )		Non-Small Cell Lung Cancer
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free